BHEL MoU + Ranbaxy WHO Qualification + Anant Raj Stock Split

Bharat Heavy Electricals Ltd [BHEL] and NTPC have signed a MOU to form a joint venture company with the propose to work jointly to complement their respective strength and to carry out engineering procurement and construction (EPC) activities in the power sector.

Ranbaxy Laboratories has announced that the WHO, Geneva, has included three more Anti Retroviral (ARV) products of the company in its pre-qualification list taking the total to 15 ARVs.

These ARVs are made available in compliance Kit packs, designed to enhance patient compliance for medication and are the company’s latest additions to the WHO list. These packs contain two fixed dose combination tablets of lamivudine / zidovudine or lamivudine / stavudine with a single tablet of efavirenz. Among these, lamivudine / stavudine + efavirenz formulations are the first by any company on the WHO list.

Anant Raj Industries approves stock split. Each 1 equity share of Rs 10 each will be split into 5 equity shares of Rs 2 each.